Improving Functions in Veterans With Post-traumatic Peripheral Neuropathic Pain

NCT02979925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2021-07-12

Study results available
· View outcomes & findings →

Summary

The proposed study will set the foundation for future multi-center studies. To validate tMS as a non-contact and non-invasive pain treatment option for reducing pain in Veterans with PTP-NP and improving their overall functions.

Conditions

  • Neuropathic Pain

Interventions

DEVICE

Active Transcutaneous Magnetic Stimulation

Active transcutaneous magnetic stimulation (TMS) at the target site of nerve damage/injury.

DEVICE

Sham Transcutaneous Magnetic Stimulation

Sham TMS will consist of the same parameters as active, however, the subject will be shielded from the magnetic field of the coil.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Albert Yick Leung, MD · VA San Diego Healthcare System, San Diego, CA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2019-09-30
Completion
2019-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02979925 on ClinicalTrials.gov